|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Malvezzi M, Carioli G, Bertuccio P, Rosso
T, Boffetta P, Levi F, La Vecchia C and Negri E: European cancer
mortality predictions for the year 2016 with focus on leukaemias.
Ann Oncol. 27:725–731. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Basturk O, Saka B, Balci S, Postlewait LM,
Knight J, Goodman M, Kooby D, Sarmiento JM, El-Rayes B, Choi H, et
al: Substaging of lymph node status in resected pancreatic ductal
adenocarcinoma has strong prognostic correlations: Proposal for a
revised N classification for TNM staging. Ann Surg Oncol. 22(Suppl
3): S1187–S1195. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tam WL and Weinberg RA: The epigenetics of
epithelial-mesen-chymal plasticity in cancer. Nat Med.
19:1438–1449. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Friedl P, Hegerfeldt Y and Tusch M:
Collective cell migration in morphogenesis and cancer. Int J Dev
Biol. 48:441–449. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alexander S, Koehl GE, Hirschberg M,
Geissler EK and Friedl P: Dynamic imaging of cancer growth and
invasion: A modified skin-fold chamber model. Histochem Cell Biol.
130:1147–1154. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Christiansen JJ and Rajasekaran AK:
Reassessing epithelial to mesenchymal transition as a prerequisite
for carcinoma invasion and metastasis. Cancer Res. 66:8319–8326.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kerjaschki D, Bago-Horvath Z, Rudas M,
Sexl V, Schneckenleithner C, Wolbank S, Bartel G, Krieger S, Kalt
R, Hantusch B, et al: Lipoxygenase mediates invasion of
intrameta-static lymphatic vessels and propagates lymph node
metastasis of human mammary carcinoma xenografts in mouse. J Clin
Invest. 121:2000–2012. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang J, Mani SA, Donaher JL, Ramaswamy S,
Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A and
Weinberg RA: Twist, a master regulator of morphogenesis, plays an
essential role in tumor metastasis. Cell. 117:927–939. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Donato R: S100: A multigenic family of
calcium-modulated proteins of the EF-hand type with intracellular
and extracellular functional roles. Int J Biochem Cell Biol.
33:637–668. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Becker T, Gerke V, Kube E and Weber K:
S100P, a novel Ca(2+)-binding protein from human placenta. cDNA
cloning, recombinant protein expression and Ca2+ binding
properties. Eur J Biochem. 207:541–547. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Crnogorac-Jurcevic T, Missiaglia E,
Blaveri E, Gangeswaran R, Jones M, Terris B, Costello E,
Neoptolemos JP and Lemoine NR: Molecular alterations in pancreatic
carcinoma: Expression profiling shows that dysregulated expression
of S100 genes is highly prevalent. J Pathol. 201:63–74. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Arumugam T, Simeone DM, Van Golen K and
Logsdon CD: S100P promotes pancreatic cancer growth, survival, and
invasion. Clin Cancer Res. 11:5356–5364. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ohuchida K, Mizumoto K, Egami T, Yamaguchi
H, Fujii K, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M and Tanaka
M: S100P is an early developmental marker of pancreatic
carcinogenesis. Clin Cancer Res. 12:5411–5416. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Parkkila S, Pan PW, Ward A, Gibadulinova
A, Oveckova I, Pastorekova S, Pastorek J, Martinez AR, Helin HO and
Isola J: The calcium-binding protein S100P in normal and malignant
human tissues. BMC Clin Pathol. 8:22008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Barry S, Chelala C, Lines K, Sunamura M,
Wang A, Marelli-Berg FM, Brennan C, Lemoine NR and
Crnogorac-Jurcevic T: S100P is a metastasis-associated gene that
facilitates transendothelial migration of pancreatic cancer cells.
Clin Exp Metastasis. 30:251–264. 2013. View Article : Google Scholar
|
|
19
|
Naidoo K, Jones R, Dmitrovic B, Wijesuriya
N, Kocher H, Hart IR and Crnogorac-Jurcevic T: Proteome of
formalin-fixed paraffin-embedded pancreatic ductal adenocarcinoma
and lymph node metastases. J Pathol. 226:756–763. 2012. View Article : Google Scholar
|
|
20
|
Endo S, Nakata K, Ohuchida K, Takesue S,
Nakayama H, Abe T, Koikawa K, Okumura T, Sada M, Horioka K, et al:
Autophagy is required for activation of pancreatic stellate cells,
associated with pancreatic cancer progression and promotes growth
of pancreatic tumors in mice. Gastroenterology. 152:1492–1506.e24.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dosch JS, Ziemke EK, Shettigar A,
Rehemtulla A and Sebolt-Leopold JS: Cancer stem cell marker
phenotypes are reversible and functionally homogeneous in a
preclinical model of pancreatic cancer. Cancer Res. 75:4582–4592.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bachem MG, Schneider E, Gross H,
Weidenbach H, Schmid RM, Menke A, Siech M, Beger H, Grünert A and
Adler G: Identification, culture, and characterization of
pancreatic stellate cells in rats and humans. Gastroenterology.
115:421–432. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−ΔΔC(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
24
|
Austermann J, Nazmi AR, Müller-Tidow C and
Gerke V: Characterization of the Ca2+-regulated
ezrin-S100P interaction and its role in tumor cell migration. J
Biol Chem. 283:29331–29340. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Du M, Wang G, Ismail TM, Gross S, Fernig
DG, Barraclough R and Rudland PS: S100P dissociates myosin IIA
filaments and focal adhesion sites to reduce cell adhesion and
enhance cell migration. J Biol Chem. 287:15330–15344. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hammacher A, Thompson EW and Williams ED:
Interleukin-6 is a potent inducer of S100P, which is up-regulated
in androgen-refractory and metastatic prostate cancer. Int J
Biochem Cell Biol. 37:442–450. 2005. View Article : Google Scholar
|
|
27
|
Feurino LW, Zhang Y, Bharadwaj U, Zhang R,
Li F, Fisher WE, Brunicardi FC, Chen C, Yao Q and Min L: IL-6
stimulates Th2 type cytokine secretion and upregulates VEGF and
NRP-1 expression in pancreatic cancer cells. Cancer Biol Ther.
6:1096–1100. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Arumugam T, Simeone DM, Schmidt AM and
Logsdon CD: S100P stimulates cell proliferation and survival via
receptor for activated glycation end products (RAGE). J Biol Chem.
279:5059–5065. 2004. View Article : Google Scholar
|
|
29
|
Arumugam T, Ramachandran V, Gomez SB,
Schmidt AM and Logsdon CD: S100P-derived RAGE antagonistic peptide
reduces tumor growth and metastasis. Clin Cancer Res. 18:4356–4364.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nguyen CH, Senfter D, Basilio J, Holzner
S, Stadler S, Krieger S, Huttary N, Milovanovic D, Viola K,
Simonitsch-Klupp I, et al: NF-κB contributes to MMP1 expression in
breast cancer spheroids causing paracrine PAR1 activation and
disinte-grations in the lymph endothelial barrier in vitro.
Oncotarget. 6:39262–39275. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chandramouli A, Mercado-Pimentel ME,
Hutchinson A, Gibadulinová A, Olson ER, Dickinson S, Shañas R,
Davenport J, Owens J, Bhattacharyya AK, et al: The induction of
S100p expression by the Prostaglandin E (PGE signaling pathway in
colon cancer cells. Cancer Biol Ther2 2)/EP4 receptor.
10:1056–1066. 2010. View Article : Google Scholar
|
|
32
|
Averboukh L, Liang P, Kantoff PW and
Pardee AB: Regulation of S100P expression by androgen. Prostate.
29:350–355. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kino T, Manoli I, Kelkar S, Wang Y, Su YA
and Chrousos GP: Glucocorticoid receptor (GR) beta has intrinsic,
GRalpha-independent transcriptional activity. Biochem Biophys Res
Commun. 381:671–675. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hamada S, Satoh K, Hirota M, Fujibuchi W,
Kanno A, Umino J, Ito H, Satoh A, Kikuta K, Kume K, et al:
Expression of the calcium-binding protein S100P is regulated by
bone morpho-genetic protein in pancreatic duct epithelial cell
lines. Cancer Sci. 100:103–110. 2009. View Article : Google Scholar
|
|
35
|
Gibadulinova A, Tothova V, Pastorek J and
Pastorekova S: Transcriptional regulation and functional
implication of S100P in cancer. Amino Acids. 41:885–892. 2011.
View Article : Google Scholar
|
|
36
|
Ebrahimi B, Tucker SL, Li D, Abbruzzese JL
and Kurzrock R: Cytokines in pancreatic carcinoma: Correlation with
phenotypic characteristics and prognosis. Cancer. 101:2727–2736.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nixon AB, Pang H, Starr MD, Friedman PN,
Bertagnolli MM, Kindler HL, Goldberg RM, Venook AP and Hurwitz HI;
Alliance for Clinical Trials In Oncology: Prognostic and predictive
blood-based biomarkers in patients with advanced pancreatic cancer:
Results from CALGB80303 (Alliance). Clin Cancer Res. 19:6957–6966.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pop VV, Seicean A, Lupan I, Samasca G and
Burz CC: IL-6 roles - Molecular pathway and clinical implication in
pancreatic cancer - A systemic review. Immunol Lett. 181:45–50.
2017. View Article : Google Scholar
|
|
39
|
Shang X, Cheng H and Zhou R: Chromosomal
mapping, differential origin and evolution of the S100 gene family.
Genet Sel Evol. 40:241–264. 2008. View Article : Google Scholar
|
